180,023views
00:00 / 00:00
Respiratory system
Choanal atresia
Laryngomalacia
Allergic rhinitis
Nasal polyps
Upper respiratory tract infection
Sinusitis
Laryngitis
Retropharyngeal and peritonsillar abscesses
Bacterial epiglottitis
Nasopharyngeal carcinoma
Tracheoesophageal fistula
Congenital pulmonary airway malformation
Pulmonary hypoplasia
Neonatal respiratory distress syndrome
Transient tachypnea of the newborn
Meconium aspiration syndrome
Apnea of prematurity
Sudden infant death syndrome
Acute respiratory distress syndrome
Pulmonary changes at high altitude and altitude sickness
Decompression sickness
Cyanide poisoning
Methemoglobinemia
Emphysema
Chronic bronchitis
Asthma
Cystic fibrosis
Bronchiectasis
Alpha 1-antitrypsin deficiency
Restrictive lung diseases
Sarcoidosis
Idiopathic pulmonary fibrosis
Hypersensitivity pneumonitis
Pneumonia
Croup
Bacterial tracheitis
Lung cancer
Pancoast tumor
Superior vena cava syndrome
Pneumothorax
Pleural effusion
Mesothelioma
Pulmonary embolism
Pulmonary edema
Pulmonary hypertension
Sleep apnea
Apnea of prematurity
Respiratory distress syndrome: Pathology review
Cystic fibrosis: Pathology review
Pneumonia: Pathology review
Tuberculosis: Pathology review
Deep vein thrombosis and pulmonary embolism: Pathology review
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Obstructive lung diseases: Pathology review
Restrictive lung diseases: Pathology review
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Lung cancer and mesothelioma: Pathology review
Pulmonary embolism
0 / 12 complete
0 / 4 complete
of complete
of complete
2022
2021
2020
2019
2018
2017
2016
pulmonary embolism p. 697
with pulmonary embolism p. 697
pulmonary emboli p. 697
chronic thromboembolism p. 703
deep venous thrombosis and p. 697
direct factor Xa inhibitors for p. 443
heparin for p. 443
respiratory alkalosis p. 616
tamoxifen/raloxifene and p. 449
thrombolytics for p. 445
ventilation/perfusion with p. 691
pulmonary embolism p. 697
pulmonary embolism p. 697
pulmonary embolism p. 697
pulmonary embolism p. 697
A pulmonary embolism happens when an embolus, which is a type of blockage, suddenly gets lodged inside a pulmonary artery.
Depending on which pulmonary artery or arteries are affected by the blockage, that can seriously decrease the amount of oxygenated blood that gets out to the body.
Normally, blood makes it back to the heart from all of the tissues and organs through a network of veins that merge over and over.
Superficial veins drain blood into deep veins, which rely on the skeletal muscle pump to move blood forward. The way it works is that the surrounding skeletal muscles compress the vein and propel blood forward, and the veins prevent blood from moving backwards by using one-way valves.
Ultimately, all of the blood ends up in the superior or inferior vena cava and dumps into the right atrium.
From there the blood goes into the right ventricle and gets pumped into pulmonary artery and eventually into the lungs.
The pulmonary artery splits at a spot called the pulmonary saddle, which looks like a bit like a horse saddle, and then the right and left pulmonary arteries enter their respective lungs.
Subsequent branches off the pulmonary artery lead to smaller and smaller arteries, then arterioles, and finally capillaries that form nets around the alveoli, which is where gas exchange occurs.
Pulmonary embolism (PE) is a blockage of the lungs main artery or one of its branches by a substance that has traveled from elsewhere in the body through the bloodstream (embolism). PE most commonly results from a deep vein thrombosis (commonly a blood clot in a leg) that breaks off and migrates to the lung, a process termed venous thromboembolism (VTE). This can cause serious damage to the lung tissue and can be life-threatening.
Symptoms vary by the amount of downstream lung tissue denied blood, which creates a ventilation-perfusion mismatch. They include shortness of breath, chest pain, and coughing. PE can also cause low blood oxygen levels, which can lead to confusion, loss of consciousness, and even death. Treatment of PE typically involves supportive therapy and blood thinning medications to dissolve the clot and prevent further clots from forming. Sometimes a filter is placed in the vena cava to trap clots before they reach the lungs.
Copyright © 2023 Elsevier, except certain content provided by third parties
Cookies are used by this site.
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.